Display options
Share it on

Open J Bioresour. 2017;4. doi: 10.5334/ojb.28. Epub 2017 Feb 20.

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.

Open journal of bioresources

Eliana M Lacerda, Erinna W Bowman, Jacqueline M Cliff, Caroline C Kingdon, Elizabeth C King, Ji-Sook Lee, Taane G Clark, Hazel M Dockrell, Eleanor M Riley, Hayley Curran, Luis Nacul

Affiliations

  1. CureME Research Team, International Centre for Evidence in Disability (ICED), Department of Clinical Research (CRD), Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.
  2. Department of Immunology & Infection, Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.
  3. Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.

PMID: 28649428 PMCID: PMC5482226 DOI: 10.5334/ojb.28

Abstract

The UK ME/CFS Biobank was launched in August 2011 following extensive consultation with professionals and patient representatives. The bioresource aims to enhance research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), related to pathophysiology, biomarkers and therapeutic approaches. The cohort includes 18-60 year olds, encompassing 284 clinically-confirmed ME/CFS cases, 60 neurologist-diagnosed multiple sclerosis (MS) cases, and 135 healthy individuals. The Biobank contains blood samples, aliquoted into serum, plasma, peripheral blood mononuclear cells (PBMC), red blood cells/granulocyte pellet, whole blood, and RNA (totalling 29,863 aliquots). Extensive dataset (700 clinical and socio-demographic variables/participant) enables comprehensive phenotyping. Potential reuse is conditional to ethical approval.

Keywords: Myalgic Encephalomyelitis / Chronic Fatigue Syndrome; biobank; biospecimen; database; multiple sclerosis

References

  1. Arch Intern Med. 2003 Jul 14;163(13):1530-6 - PubMed
  2. Sleep. 1991 Dec;14(6):540-5 - PubMed
  3. Sleep. 2008 Nov;31(11):1601-7 - PubMed
  4. J R Soc Med. 1991 Feb;84(2):118-21 - PubMed
  5. BMC Public Health. 2009 Dec 11;9:458 - PubMed
  6. BMC Res Notes. 2011 May 09;4:139 - PubMed
  7. J Intern Med. 2011 Oct;270(4):327-38 - PubMed
  8. BMC Med. 2011 Jul 28;9:91 - PubMed
  9. J Physiother. 2011;57(4):259 - PubMed
  10. Eval Health Prof. 2012 Sep;35(3):280-304 - PubMed
  11. Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52 - PubMed
  12. BMC Med Inform Decis Mak. 2013 Jul 19;13:72 - PubMed
  13. PLoS One. 2013 Dec 02;8(12):e80704 - PubMed
  14. BMJ Open. 2014 Feb 07;4(2):e003973 - PubMed
  15. Mil Med. 2015 Jul;180(7):721-3 - PubMed
  16. J Infect Dis. 2016 Feb 1;213(3):485-95 - PubMed
  17. Arch Neurol. 1989 Oct;46(10):1121-3 - PubMed
  18. Lancet. 1974 Nov 9;2(7889):1127-31 - PubMed
  19. Psychol Med. 1979 Feb;9(1):139-45 - PubMed
  20. Ann Intern Med. 1994 Dec 15;121(12):953-9 - PubMed

Publication Types

Grant support